Interim ruling on glyphosate overturned; EPA expects final registration in 2026

The Environmental Protection Agency has withdrawn its interim decision on glyphosate, the active ingredient in Roundup, and says it will complete its registration review in 2026.

The agency announced its latest decision on Friday in response to a June opinion from the US Court of Appeals for the 9th Circuit which vacated the human health portion of the EPA’s interim decision after finding that cancer testing was flawed. It also reversed, but did not overturn, the agency’s environmental risk assessment after finding that the interim decision should not have been issued without an “impact determination” detailing the impact on endangered species.

The EPA faced an Oct. 1 deadline to complete the registration, but the recall was expected, Roundup maker Bayer said.

The Center for Food Safety, which was one of the plaintiffs in the lawsuit, called the EPA’s announcement a “major victory” but also “an irresponsible attempt to circumvent the court’s deadline to correct violations of the law.”

The court ordered the EPA to complete a new environmental risk analysis by October 1. However, the EPA told the court it could not meet that deadline and has now decided to withdraw that analysis and work on all aspects of the glyphosate registration review, with a goal of completion by 2026.

In the meantime, “pesticide products containing glyphosate continue to remain on the market and used in accordance with the product label and are not affected by this action,” the EPA said in a statement.

“The EPA is allowing glyphosate to be sold and sprayed despite major unresolved questions about its safety for health and the environment,” the Center for Food Safety said. “It should be done by the EPA instead cancel glyphosate products until and unless he reassesses his risks and ensures his safety through legal means. Can’t: Due to cancer concerns, Monsanto/Bayer have already agreed to stop selling Roundup to consumers by 2023. Now the EPA must eliminate its other uses as well.”

Bayer said the recall “does not affect the registration of glyphosate or Roundup products, nor does it change the conclusions that the EPA has repeatedly reached regarding the safety and non-carcinogenicity of these products. The interim decision was an agency discretion, and as a result, EPA could withdraw it. The withdrawal was also expected as the EPA indicated it was considering the action in its petition for reconsideration in the 9th Circuit. The court rejected the petition last month.

“EPA has confirmed that it is conducting additional work under 9thousand The county’s June decision,” Bayer said. “We remain confident, based on the extensive scientific evidence supporting its safety, that the agency will again conclude that glyphosate is safe to use and is not carcinogenic, as it has been for decades, consistent with the findings of other regulatory agencies experts all over the world.”

The EPA said it did not seek to change the labeling of glyphosate products to implement the risk reduction measures identified in the interim decision “because EPA’s continued work to complete its review of the glyphosate registration may affect what risk reduction measures EPA may determine to be necessary.” , the agency said. his last decision.

The agency says it continues to work on a petition from the Environmental Working Group calling for reduced oat tolerance and label changes, as well as label changes based on concerns about dietary exposure and carcinogenicity.

The agency also continues its Endangered Species Act consultations with federal wildlife agencies.

For more news, go to Interim ruling on glyphosate overturned; EPA expects final registration in 2026

Back to top button